Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation; plus, Passionfroot raises $15M to expand its B2B creator marketplace to the US

TechCrunch Startup News by SpokenLayer

Colossal Biosciences is in talks to raise new funding at a $20 billion to $30 billion valuation, Axios reported. Also, Passionfroot, a German startup building a marketplace connecting B2B creators with brands, has raised...View more